FDA approves ImClone's Erbitux; drug to be available in two weeks

02/13/2004 | Wall Street Journal, The

The FDA gave its approval of ImClone Systems' Erbitux as a treatment for aggressive colon cancer, making it the company's first product to receive federal clearance. The approval came two years after the agency first denied ImClone approval of the drug, a decision that led to responses resulting in the Martha Stewart insider-trading scandal. Bristol-Myers Squibb, co-developer of Erbitux with ImClone, said the drug would be available on the market in two weeks.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR